Login
Population (2005)
32.7m
GDP (PPP data, 2004)
$134.6bn
Health expenditure (2002)
Health expenditure as proportion of GDP (2002)
Size of pharmaceutical market (sales, 2004)
Percentage of GDP spent on pharmaceuticals (2002)
Percentage of health expenditure spent on medicines (2002)
Pharmaceutical market growth rate (2004)
Local currency
Moroccan Dirham (DH)
Summary: Morocco
The pharmaceutical market in Morocco is characterised by the large socio-economic disparities and the different levels of consumption between rural and urban areas. Although medicine prices are on average 30% lower than those in France, they are high when compared with average income per inhabitant.
The situation is changing as the authorities are to introduce a national system of health insurance, and this will certainly stimulate demand of pharmaceuticals. In addition, the government is changing industry regulations to allow pharmaceutical producers to open up to foreign capital. The restriction that 51% of the capital be held by Moroccans is being removed to entice large foreign investors and support laboratory growth.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
07/05/2005
Authorities to revise the Medicine and Pharmacy Code
25/04/2005
Morocco evades wrath of PhRMA
10/04/2005
Authorities to establish universal mandatory health insurance
Related Items